PUBLICATIONS
- Fabrizio Bianchi
- Sep 12, 2022
- 3 min read
Updated: Jan 19, 2023
List of publications (Most relevant):
Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi MP, Mazzarelli F, Melocchi V, Palumbo O, Marino E, Belloni E, Montani F, Vecchi M, Barberis M, Graziano P, Pasquier A, Sanz-Ortega J, Montuenga LM, Carbonelli C, Spaggiari L, Bianchi F. miRNOME profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. J Hematol Oncol. 2022 Dec 31;15(1):178. doi: 10.1186/s13045-022-01394-1. PMID: 36587234; PMCID: PMC9805174. https://pubmed.ncbi.nlm.nih.gov/36587234/
Colangelo T, Carbone A, Mazzarelli F, Cuttano R, Dama E, Nittoli T, Albanesi J, Barisciano G, Forte N, Palumbo O, Graziano P, di Masi A, Colantuoni V, Sabatino L, Bianchi F, Mazzoccoli G. Loss of circadian gene Timeless induces EMT and tumor progression in colorectal cancer via Zeb1-dependent mechanism. Cell Death Differ. 2022 Aug;29(8):1552-1568. doi: 10.1038/s41418-022-00935-y. PMID: 35034102; PMCID: PMC9345857. https://pubmed.ncbi.nlm.nih.gov/35034102/
Cuttano, T, Afanga, Bianchi, F (2022) MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going. Cancers (Basel) ;14(23):5731. doi: 10.3390/cancers14235731.PMID: 36497213 PMCID: PMC9740066
Colangelo T, Carbone A, Mazzarelli F, Cuttano R, Dama E, Nittoli T, Albanesi J, Barisciano G, Forte N, Palumbo O, Graziano P, di Masi A, Colantuoni V, Sabatino L, Bianchi F*, Mazzoccoli G* (2022) Loss of circadian gene Timeless induces EMT and tumor progression in colorectal cancer via Zeb1-dependent mechanism. Cell Death and Differentiation. doi: 10.1038/s41418-022-00935-y. Epub ahead of print. PMID: 35034102. * co-last authorship
Dama E, Colangelo T, Fina E, Cremonesi M, Kallikourdis M, Veronesi G, Bianchi F. (2021) Biomarkers and Lung Cancer Early Detection: State of the Art. Cancers (Basel) ;13(15):3919. doi: 10.3390/cancers13153919. PMID: 34359818; PMCID: PMC8345487.
Melocchi V, Dama E, Mazzarelli F, Cuttano R, Colangelo T, Di Candia L, Lugli E, Veronesi G, Pelosi G, Ferretti GM, Taurchini M, Graziano P, Bianchi F. (2021) Aggressive early-stage lung adenocarcinoma is characterised by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.Oncogene. ;40(31):4980-4991. doi: 10.1038/s41388-021-01909-z. Epub 2021 Jun 25. PMID: 34172935.
Barisciano G, Colangelo T, Rosato V, Muccillo L, Letizia Taddei M, Ippolito L, Chiarugi P, Galgani M, Bruzzaniti S, Matarese G, Fassan M, Agostini M, Bergamo F, Pucciarelli S, Carbone A, Mazzoccoli G, Colantuoni V, Bianchi F*, Sabatino L*. (2020) miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. British Journal of Cancer. doi: 10.1038/s41416-020-0773-2. [Epub ahead of print] PubMed PMID: 32132656. * co-last authorship
Lusito E, Felice B, D'Ario G, Ogier A, Montani F, Di Fiore PP, Bianchi F. Unraveling the role of low-frequency mutated genes in breast cancer. (2019) Bioinformatics. doi: 10.1093/bioinformatics/bty520
Monterisi S, Lo Riso P, Russo K, Bertalot G, Vecchi M, Testa G, Di Fiore PP, Bianchi F. (2018) HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype.Oncogene. ;37(26):3575-3588. doi: 10.1038/s41388-018-0229-9.
Dama E, Melocchi V, Dezi F, Pirroni S, Carletti RM, Brambilla D, Bertalot G, Casiraghi M, Maisonneuve P, Barberis M, Viale G, Vecchi M, Spaggiari L, Bianchi F*, Di Fiore PP* (2017)
An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers. Clinical Cancer Research;23(1):62-72. doi: 10.1158/1078-0432.CCR-15-3005. * co-last authorship
Montani, F, Bianchi F. (2016) Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA. EBioMedicine. 2016 Feb 28;5:4-6. doi: 10.1016/j.ebiom.2016.02.038. eCollection
Montani, F., Marzi, M., Dezi, F., Dama, E., Carletti, R., Bonizzi, G., Bertolotti, R., Bellomi, M., Rampinelli, C., Maisonneuve, P., Spaggiari, L., Veronesi, G., Nicassio, F., Di Fiore, PP., Bianchi, F. (2015) miR-Test: a blood test for lung cancer early detection, Journal of the National Cancer Institute 107(6), doi:10.1093/jnci/djv063
Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G, Di Fiore PP. (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Molecular Medicine (8):495-503. doi: 10.1002/emmm.201100154.
Yorumlar